课题基金 / 基金详情

RECOMBINANT HUMAN INTERLEUKIN ELEVEN IN RHEUMATOID ARTHRITIS

RECOMBINANT HUMAN INTERLEUKIN ELEVEN IN RHEUMATOID ARTHRITIS
重组人白细胞介素 11 在类风湿性关节炎中的应用
批准号:
6118059
负责人:
MICHAEL H WEISMAN
金额:
$1.46万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

MICHAEL H WEISMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Assess the safety of rhIL-11 when administered to subjects with active rheumatoid arthritis, make a preliminary measure of clinical activity using ACR criteria for improvement, and explore dosing for future clinical trials. Assessment tools to be used include tender joint count, swollen joint count, assessment of pain, global assessment of disease activity by patient and physician, patient's assessment of physical function, and c-reactive protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY OF ORAL CCII IN TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS
INDUCTION COURSE & MAINTENANCE CYCLE OF AG4263 IN RHEUMATOID ARTHRITIS
LJP 394 ADMINISTERED TO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
RO32 3555 TROCADE IN STRUCTURAL JOINT DAMAGE IN RHEUMATOID ARTHRITIS
海外基金